Authors:
NARANJO CA
POULOS CX
LANCTOT KL
BREMNER KE
KWOK M
UMANA M
Citation: Ca. Naranjo et al., RITANSERIN, A CENTRAL 5-HT2 ANTAGONIST, IN HEAVY SOCIAL DRINKERS - DESIRE TO DRINK, ALCOHOL INTAKE AND RELATED EFFECTS, Addiction, 90(7), 1995, pp. 893-905
Citation: Kl. Lanctot et al., BAYESIAN DIFFERENTIAL-DIAGNOSIS OF SEVERE CUTANEOUS ADVERSE REACTIONSASSOCIATED WITH MEFLOQUINE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 155-155
Authors:
BUSTO UE
CURRIE N
KWOK M
KALVIK A
NARANJO CA
Citation: Ue. Busto et al., COMPLIANCE WITH MEDICATION IN CLINICAL-TRIALS - IMPLICATIONS FOR DATAINTERPRETATION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 156-156
Authors:
OH PI
KWOK M
SHEAR NH
LANCTOT KL
KNOWLES S
NARANJO CA
Citation: Pi. Oh et al., A COMPARISON OF METHODS FOR THE ASSESSMENT OF SUSPECTED ADVERSE DRUG REACTION IN THE CLINIC SETTING, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 156-156
Authors:
KALVIK A
KWOK M
TSENG A
CURRIE N
BUSTO UE
NARANJO CA
Citation: A. Kalvik et al., VARIATIONS IN MEDICATION MANAGEMENT-SYSTEMS (MEMS(R)) PERFORMANCE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 157-157